FDA to Allow Biosimilar Makers to Use European Drug Samples

July 25, 2018

The Food and Drug Administration (FDA) will close a loophole in the drug regulatory system by allowing U.S. drugmakers that create cheaper versions of expensive biologic drugs to use European drugs as a reference.

Related Stories